Galderma Group AG (SWX:GALD)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
111.80
+1.10 (0.99%)
Jun 3, 2025, 5:31 PM CET
52.59%
Market Cap 26.54B
Revenue (ttm) 4.02B
Net Income (ttm) 209.33M
Shares Out 237.41M
EPS (ttm) 0.88
PE Ratio 127.19
Forward PE 45.82
Dividend 0.15 (0.14%)
Ex-Dividend Date Apr 25, 2025
Volume 388,233
Average Volume 1,501,603
Open 111.70
Previous Close 110.70
Day's Range 110.50 - 112.70
52-Week Range 64.75 - 119.60
Beta n/a
RSI 76.46
Earnings Date Jul 24, 2025

About Galderma Group AG

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services that span the spectrum of the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Dysport/Azzalure, Alluzience, Restylane, and Sculptra in injectable aesthetics; Cetaphil and Alastin in dermatological skincare; and Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac, and Loceryl in therapeutic ... [Read more]

Sector Healthcare
Founded 1981
Employees 6,545
Stock Exchange SIX Swiss Exchange
Ticker Symbol GALD
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.